# Norwegian Intensive Care Unit Dalteparin Effect Study

> **NCT01721928** · — · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 70 (actual)

## Conditions studied

- Acute Kidney Injury
- Deep Venous Thrombosis

## Interventions

- **DEVICE:** Continuous venovenous hemodialysis

## Key facts

- **NCT ID:** NCT01721928
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-03
- **Primary completion:** 2016-06-02
- **Final completion:** 2017-03-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2017-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721928, "Norwegian Intensive Care Unit Dalteparin Effect Study". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT01721928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*